Instrument number PB 56 of 2008
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 1st May 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 June 2008.
2 Amendment of PB 93 of 2007
Schedule 1 amends PB 93 of 2007.
Schedule 1 Amendments
[1] Schedule 2, item dealing with Oxaliplatin in the form Powder for
I.V. infusion 50 mg
omit from the column headed “Brand”:
Oxaliplan 50
[2] Schedule 2, item dealing with Oxaliplatin in the form Powder for
I.V. infusion 100 mg
omit from the column headed “Brand”:
Oxaliplan 100